Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 7/20 | 0.54 |
| ▸ | MAOB | P27338 | 11/20 | 0.49 |
| ▸ | MAOA | P21397 | 5/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.49 |
| ▸ | SDHA | P31040 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CALML3 | P27482 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8863005 | 0.92 | F10 (0.54) | F10MAOBMAOAPTGS1SDHA | |
| Hydrochloric Acid SCHEMBL8574357 | 0.91 | F10 (0.53) | F10MAOBMAOAPTGS1SDHA | |
| SCHEMBL3395911 | 0.91 | F10 (0.51) | F10MAOBMAOAPTGS1SDHA | |
| SCHEMBL7846944 | 0.91 | F10 (0.51) | F10MAOBMAOAPTGS1SDHA | |
| SCHEMBL5472893 | 0.89 | MAOB (0.62) | F10MAOBMAOAPTGS1SDHA | |
| SCHEMBL3394104 | 0.87 | F10 (0.51) | F10MAOBMAOAPTGS1SDHA | |
| SCHEMBL5823804 | 0.82 | MAOB (0.44) | F10MAOBMAOAPTGS1SDHA | |
| SCHEMBL1802813 | 0.81 | MAOB (0.53) | F10MAOBMAOAPTGS1SDHA | |
| SCHEMBL1805573 | 0.81 | MAOB (0.53) | F10MAOBMAOAPTGS1SDHA | |
| SCHEMBL6767666 | 0.81 | MAOB (0.40) | MAOBMAOAPTGS1SDHALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005090339-A1 | NEW ANTIBACTERIAL AGENTS | ORCHID CHEMICALS PHARMACEUTICALS LTD (IN) | 2005-09-29 | — | — | WO | disclosed |
| US-20050203102-A1 | antibacterial agents | ORCHID CHEMICALS & PHARMACEUTICALS LTD. (IN) | 2005-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203102-A1 | antibacterial agents | MRPL21, OXA1L, NDUFS5 | F10 3157/4885MAOB 2365/4885MAOA 2266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.